Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand ... to change,” says the company’s CEO David Ricks.

Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...

Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions ... effective as of Q4 2023. Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

RFG Advisory LLC boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 13.4% in the fourth quarter, ...

Private Capital Advisors Inc. grew its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.1% during ...

Eli Lilly and Company discovers ... Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin ...

Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology. Having examined the options trading patterns of Eli Lilly, our attention now turns directly to the company.

Humalog + Insulin Lispro have maintained a dominant ... in this case calculated on the basis of the last 12 months. Eli Lilly is an outstanding company, but the market may have overestimated ...

The company’s main products include Humalog, Trulicity ... transfer to locally manufacture the insulin. This initiative is part of Eli Lilly’s 30×30 goal, aimed at enhancing healthcare ...

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the ...